ex.VAT:
VAT:
inc.VAT:

The unmissable event of this year
Tuesday, September 12, 2017Regulation

Phenylene Bis-Diphenyltriazine (S86): 2nd Request for Opinion to SCCS

© CosmeticOBS-L'Observatoire des Cosmétiques

The safety of the UV-Filter Phenylene Bis-Diphenyltriazine (S86) will be re-assessed by the SCCS. The request from the European Commission, following the submission of a new dossier par Pierre Fabre Laboratories was published on September 7, 2017.

Reading time
~ 3 minutes

Background

Following submission I on Phenylene Bis-Diphenyltriazine to assess its safety for use in cosmetic products, the SCCS concluded in its Opinion in July 2015 (SCCS/1556/15) that:
'The following conclusions apply to Phenylene bis-diphenyltriazine with median particle size distribution (number-sized) around 130-170 nm or larger.
 1. Does the SCCS consider Phenylene bis-diphenyltriazine, S86, safe for use as a UV-filter in sunscreen products in a concentration up to 10.0% taking into account the scientific data provided?
The SCCS considers Phenylene bis-diphenyltriazine, S86, not safe for use as a UV-filter in sunscreen products in a concentration up to 10.0% taking into account the scientific data provided.
SCCS cannot exclude that Phenylene bis-diphenyltriazine may have a genotoxic potential.
 2. Does the SCCS have any further scientific concerns with regard to the use of Phenylene bis-diphenyltriazine, S86, as a UV-filter in sunscreen and/or other cosmetic products?
An adequate physico-chemical characterisation should be provided.
The tests conducted on eye irritation and skin sensitisation are considered inconclusive.
The phototoxicity potential can as yet not be excluded.
This Opinion does not apply to inhalation exposure of Phenylene bis-diphenyltriazine since no adequate information on chronic or sub-chronic toxicity after inhalation was provided.
The SCCS noted that due to …

This content is only available to subscribersPRO, PREMIUM, STARTUP and TPE

Already subscribed?Log in

Discover our subscriptions


Associated elements(2)

Your 2024 class program

RegulationOther articles